HealthCor Management, L.P. - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 166 filers reported holding REVANCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
HealthCor Management, L.P. ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$1,744,000
-91.1%
64,590
-95.4%
0.22%
-88.9%
Q2 2022$19,598,000
-29.4%
1,418,088
-0.4%
1.97%
+6.3%
Q1 2022$27,757,000
+17.3%
1,423,425
-1.8%
1.85%
+43.8%
Q4 2021$23,661,000
+941.9%
1,449,835
+1678.9%
1.29%
+1214.3%
Q3 2021$2,271,00081,5000.10%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
NovaQuest Capital Management, L.L.C. 1,558,426$48,000,00065.50%
Essex Woodlands Management, Inc. 3,842,047$118,335,00025.90%
Rhenman & Partners Asset Management AB 203,181$6,258,0000.77%
EAM Global Investors LLC 44,898$1,383,0000.72%
Fosun International Ltd 319,313$9,835,0000.62%
EAM Investors, LLC 113,096$3,483,0000.58%
ArrowMark Colorado Holdings LLC 1,735,699$53,460,0000.53%
Perceptive Advisors 618,957$19,064,0000.53%
ESSEX INVESTMENT MANAGEMENT CO LLC 111,360$3,430,0000.45%
Schonfeld Strategic Advisors LLC 83,700$2,578,0000.19%
View complete list of REVANCE THERAPEUTICS INC shareholders